WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'5701 Infant (under 12 months) mortality rate: 442
GDP / capita (US$): 5'4101 Child (under 5 years) mortality rate: 562

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'252'140  1'236'687  1'221'156  1'205'625  1'190'138  1'042'262  868'891  698'966 
Births 25'595  25'642  25'666  25'682  25'713  26'726  26'665  24'511 
Surviving infants 24'492  24'504  24'493  24'474  24'468  25'054  24'521  21'953 
Pop. less than 5 years 121'293  120'581  120'466  121'283  121'880  122'974  119'128  103'456 
Pop. less than 15 years 364'250  363'817  363'548  363'764  363'840  356'661  325'836  274'586 
Female 15-49 years 323'710  319'537  315'170  310'529  306'021  260'502  206'043  162'250 

Number of reported case

(Click for retrospective incidence data for India)
Diphtheria 3'133  2'525  4'233  3'434  3'529  5'125  8'425  39'231 
Japanese encephalitis 1'078  1'214  555  653 
Measles 13'822  18'668  33'634  31'458  56'188  38'835  89'612  114'036 
Mumps
Pertussis 31'089  44'154  39'091  40'508  60'385  31'431  112'416  320'109 
Polio* 43  762  265  10'408  18'975 
Rubella 3'698  1'232 
Rubella (CRS)
Tetanus (neonatal) 415  588  734  521  898  3'287  9'313 
Tetanus (total) 2'814  2'404  2'843  1'756  2'126  8'997  23'356  45'948 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for India)
Vaccine year result method % card seen                                                
BCG 2008  87  CES   52  92  100  100  96  97  99*  100 
DTP1 2008  83  CES   52  99  90  90  94  96 
DTP3 2008  72  CES   52  76  85  85  90  97  94  100  53 
HepB_BD          33  30 
HepB3 2008  59  CES   52  67  70  47  91  34 
Hib3          87 
JapEnc          69  65  63  37 
MCV 2008  74  CES   52  88  85  85  87  94  89  91 
MCV2          42  50  30 
PCV1         
PCV3         
Pol3 2008  70  CES   52  88  85  85  90  99*  95  100  42 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  60  MICS     61  90  90  79  80  80  78  22 
PAB         
VAD1          70  90  90  88  84 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for India)
BCG 87  87  87  87  87  74  66 
DTP1 88  88  88  88  88  81  88  25 
DTP3 72  72  72  72  72  60  70 
HepB3 67  70  47  37  34 
HepB_BD 33  30  22  15 
Hib3 20 
MCV 74  74  74  74  74  59  56 
MCV2 42  50  30 
PAB 87  87  87  87  86  85  81  20 
PnC3
Pol3 70  70  70  70  70  59  66 
Rota_last

Number of districts in the country 659  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; 16-24 months; 5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; No
HepB Birth; 6, 10, 14 weeks; Yes
JapEnc 9-12, 16-24 months; No
Measles 9-12, 16-24 months; Yes
OPV birth; 6, 10, 14 weeks; 16-24 months; Yes
TT 10, 16 years; Yes and Preg Women
VitaminA 9, 18, 24, 30, 36, 42 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2010-2017  2010-2017  2005-10  2005-10  2005-10  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   657    644       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 659  657  645  644  655  644  604 
Nº districts with DTP3 coverage >=80% number 561  530  414  73 
% of districts with DTP3 coverage >=80% From 0 to 100% 87    64  12 
Nº districts with measles (MCV1) coverage >=95% number     461    320  228   
% of districts with MCV1 coverage >=95% From 0 to 100%     71    49  35   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 63  100  100  100    100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.